Universe Pharmaceuticals (UPC) Long-Term Deferred Tax (2020 - 2023)
Universe Pharmaceuticals (UPC) posted Long-Term Deferred Tax of $599078.0 for Q3 2023, down 27.84% sequentially from $830259.0 in Q1 2023, and down 55.55% YoY from $1.3 million in Q3 2022.
Universe Pharmaceuticals (UPC) Long-Term Deferred Tax (2020 - 2023) Analysis & Trends
Universe Pharmaceuticals has reported Long-Term Deferred Tax for 4 years, with the latest figure at $599078.0 in Q3 2023.
- Quarterly Long-Term Deferred Tax fell 55.55% year-over-year to $599078.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $599078.0 (down 55.55% YoY) and the FY2023 annual result came in at $599078.0, down 55.55% from the prior year.
- Long-Term Deferred Tax fell to $599078.0 in Q3 2023 per UPC's latest filing, from $830259.0 in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $186.5 billion in Q3 2020 and troughed at $599078.0 in Q3 2023.
- A 4-year average of $31.1 billion and a median of $927979.0 in 2021 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2021 and 2022: Long-Term Deferred Tax tumbled 100.0% in 2021, then surged 54.91% in 2022.
- Over 4 years, Long-Term Deferred Tax stood at $186.5 billion in 2020, then sank by 100.0% to $869997.0 in 2021, then soared by 54.91% to $1.3 million in 2022, then plunged by 55.55% to $599078.0 in 2023.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $599078.0, $830259.0, and $1.3 million for Q3 2023, Q1 2023, and Q3 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Universe Pharmaceuticals | 2.93 Mn | -26.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 599,078.00 |
| Mar 31, 2023 | 830,259.00 |
| Sep 30, 2022 | 1.35 Mn |
| Mar 31, 2022 | 985,961.00 |
| Sep 30, 2021 | 869,997.00 |
| Sep 30, 2020 | 186.54 Bn |